Neoseptolete Combi Eukalyptus (Benzydamine Hydrochloride, Cetylpyridinium Chloride)

Benzydamine Hydrochloride and Cetylpyridinium Chloride, the active ingredients in Neoseptolete Combi Eukalyptus, are a non‑steroidal anti‑inflammatory and antiseptic presented as an oral solution for oral use. It relieves sore throat, oral mucosal inflammation and provides antimicrobial protection in adults and children.

GNH USA supplies Neoseptolete Combi Eukalyptus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neoseptolete Combi Eukalyptus, containing benzydamine and cetylpyridinium chloride, is indicated for conditions affecting the oral cavity and pharynx.

- Sore throat: reduces pain and inflammation in the pharyngeal mucosa. - Oral mucosal inflammation: alleviates redness and swelling of the mouth lining. - Mouth ulcers: promotes symptomatic relief and helps prevent secondary infection. - Gingival irritation: soothes gum inflammation and reduces microbial load.

Benzydamine hydrochloride and cetylpyridinium chloride may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Altered taste sensation: temporary metallic or bitter taste. - Oral irritation: mild burning or tingling in the mouth. - Nausea: occasional feeling of queasiness after use. - Dry mouth: reduced salivation during treatment.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe oral ulceration: extensive mucosal breakdown beyond expected healing. - Anaphylaxis: rapid onset of systemic hypersensitivity requiring emergency care.

Before using Neoseptolete Combi Eukalyptus, consider the following precautions to ensure safe and effective treatment.

- Age restriction: avoid use in children under 2 years unless advised by a clinician. - Existing oral lesions: consult a healthcare professional if severe lesions are present. - Concurrent oral NSAIDs: monitor for increased local irritation. - Pregnancy and lactation: discuss potential risks with a physician before use. - Allergies: discontinue if signs of hypersensitivity appear. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Neoseptolete Combi Eukalyptus can interact with other medicines; awareness of major and moderate interactions helps minimise risk.

Major Interactions (Avoid): - Other topical oral NSAIDs: combined use may increase mucosal irritation. - Strong antiseptic mouthwashes (chlorhexidine): may cause additive cytotoxic effects on oral tissues. - Systemic anticoagulants: heightened risk of oral bleeding when mucosal integrity is compromised.

Moderate Interactions (Monitor Closely): - Alcohol consumption: may exacerbate burning sensation in the mouth. - Corticosteroid inhalers: monitor for increased risk of oral candidiasis. - Antihistamines: possible reduction in salivary flow, enhancing local irritation.